| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
155,918 |
151,278 |
$16.09M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
126,658 |
123,069 |
$9.17M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
32,611 |
32,602 |
$2.93M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
33,018 |
32,581 |
$2.83M |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
83,459 |
83,295 |
$2.28M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
16,977 |
16,968 |
$1.49M |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
33,883 |
33,854 |
$1.07M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
24,403 |
23,950 |
$941K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18,704 |
18,583 |
$480K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,492 |
5,471 |
$448K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,515 |
4,515 |
$432K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,728 |
2,034 |
$419K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27,030 |
26,827 |
$389K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,704 |
3,704 |
$356K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,598 |
5,598 |
$353K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,410 |
1,684 |
$348K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
10,417 |
10,368 |
$326K |
| 99381 |
|
2,575 |
2,575 |
$248K |
| 87428 |
|
5,728 |
5,703 |
$220K |
| 99051 |
|
29,723 |
29,247 |
$195K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,290 |
1,290 |
$184K |
| 90474 |
|
10,189 |
10,187 |
$184K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
18,621 |
18,350 |
$156K |
| 96161 |
|
28,436 |
26,068 |
$123K |
| 96127 |
|
29,691 |
29,088 |
$121K |
| 87634 |
|
1,391 |
1,383 |
$85K |
| 83655 |
|
6,232 |
6,219 |
$67K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,811 |
1,779 |
$66K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,430 |
3,151 |
$64K |
| 87807 |
|
3,571 |
3,533 |
$41K |
| 99383 |
|
386 |
386 |
$40K |
| 99173 |
|
9,210 |
9,205 |
$23K |
| 85018 |
|
7,891 |
7,878 |
$17K |
| 99188 |
|
1,557 |
1,557 |
$16K |
| 92523 |
|
69 |
69 |
$14K |
| 0071A |
|
349 |
349 |
$13K |
| 98966 |
|
784 |
775 |
$9K |
| 99382 |
|
88 |
88 |
$9K |
| 97166 |
|
82 |
82 |
$7K |
| 0072A |
|
171 |
170 |
$6K |
| 97162 |
|
57 |
57 |
$5K |
| 99384 |
|
27 |
27 |
$3K |
| 0001A |
|
57 |
57 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
14 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
111 |
109 |
$2K |
| 99050 |
|
77 |
76 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
86 |
74 |
$1K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
888 |
885 |
$1K |
| 94664 |
|
59 |
58 |
$842.19 |
| 96380 |
|
44 |
44 |
$778.12 |
| 99441 |
|
15 |
15 |
$737.85 |
| 98967 |
|
33 |
33 |
$716.43 |
| 0002A |
|
12 |
12 |
$480.00 |
| 80061 |
Lipid panel |
36 |
36 |
$423.44 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
132 |
132 |
$203.91 |
| 90686 |
|
8,057 |
8,052 |
$192.27 |
| 90674 |
|
2,528 |
2,528 |
$128.10 |
| A7015 |
Aerosol mask, used with dme nebulizer |
83 |
83 |
$113.98 |
| 96160 |
|
19,051 |
18,959 |
$46.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
20 |
13 |
$25.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
29 |
28 |
$17.88 |
| 36416 |
|
17 |
17 |
$8.01 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
82 |
82 |
$4.36 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$1.69 |
| J7510 |
Prednisolone oral, per 5 mg |
12 |
12 |
$1.26 |
| 90661 |
|
1,149 |
1,149 |
$0.64 |
| 90670 |
|
20,750 |
20,740 |
$0.58 |
| 90681 |
|
7,082 |
7,081 |
$0.34 |
| 90633 |
|
8,758 |
8,757 |
$0.27 |
| 90697 |
|
4,311 |
4,308 |
$0.12 |
| 90651 |
|
2,105 |
2,105 |
$0.09 |
| 90734 |
|
1,190 |
1,190 |
$0.03 |
| 90620 |
|
76 |
76 |
$0.02 |
| 90648 |
|
14,672 |
14,666 |
$0.00 |
| 90700 |
|
1,043 |
1,043 |
$0.00 |
| 90707 |
|
1,142 |
1,142 |
$0.00 |
| 90710 |
|
1,948 |
1,948 |
$0.00 |
| 90715 |
|
601 |
601 |
$0.00 |
| 91300 |
|
184 |
176 |
$0.00 |
| 90672 |
|
46 |
46 |
$0.00 |
| 90716 |
|
1,209 |
1,209 |
$0.00 |
| 90723 |
|
10,980 |
10,976 |
$0.00 |
| 91307 |
|
690 |
677 |
$0.00 |
| 90696 |
|
1,074 |
1,074 |
$0.00 |
| 90660 |
|
30 |
30 |
$0.00 |
| 90381 |
|
29 |
29 |
$0.00 |
| 90677 |
|
120 |
120 |
$0.00 |